[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456887":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":76,"collaborators":7,"id":78,"slug":7,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":79,"sex":85,"minAge":86,"maxAge":87,"enrollmentInfo":88,"targetDuration":7,"studyType":91,"phases":7,"briefSummary":92,"conditions":93,"keywords":97,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"Children's Hospital Medical Center, Cincinnati","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Paneez Khoury, MD","National Institutes of Health (NIH)","STUDY_CHAIR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Regina Yearout","CONTACT","(513) 517-2108","Regina.Yearout@cchmc.org",[20,41,60],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Northwestern University","RECRUITING","Chicago","Illinois","60208","United States",{"type":28,"coordinates":29},"Point",[30,31],-87.65005,41.85003,{"lat":31,"lon":30},[34,38],{"name":35,"role":16,"phone":36,"phoneExt":7,"email":37},"Rose Arrieta","312-695-5878","rarrieta@northwestern.edu",{"name":39,"role":40,"phone":7,"phoneExt":7,"email":7},"Nirmala Gonsalves, MD","PRINCIPAL_INVESTIGATOR",{"facility":42,"status":22,"city":43,"state":44,"zip":45,"country":26,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"The National Institutes of Health","Bethesda","Maryland","20892",{"type":28,"coordinates":47},[48,49],-77.10026,38.98067,{"lat":49,"lon":48},[52,56,59],{"name":53,"role":16,"phone":54,"phoneExt":7,"email":55},"Perla Adames-Castillo, RN","301-402-5969","perla.adamescastillo@nih.gov",{"name":57,"role":16,"phone":7,"phoneExt":7,"email":58},"Megan Koch","megan.koch@nih.gov",{"name":10,"role":40,"phone":7,"phoneExt":7,"email":7},{"facility":61,"status":22,"city":62,"state":63,"zip":64,"country":26,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"University of Utah","Salt Lake City","Utah","84112",{"type":28,"coordinates":66},[67,68],-111.89105,40.76078,{"lat":68,"lon":67},[71,74],{"name":72,"role":16,"phone":7,"phoneExt":7,"email":73},"Amy Nichols","Amy.Nichols@hsc.utah.edu",{"name":75,"role":40,"phone":7,"phoneExt":7,"email":7},"Kathryn Peterson, MD",{"type":77,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100456887",false,"NCT05229432","Study of Gastric Motility in Eosinophilic Gastritis","Pilot Assessment to Find Evidence of Gastric Motility Abnormalities in Eosinophilic Gastric Disorders","OAT-FEED","Inclusion Criteria:\n\n* Eosinophilic gastritis (EG) defined as at least one endoscopy with histopathologic evidence of ≥ 30 eosinophils in 5 or more high powered fields (hpf's) with associated symptoms of EG.\n* Patient reported symptoms starting at least one year or more prior to screening consistent with a diagnosis of EG: nausea, vomiting, early satiety, abdominal pain\u002Fbloating, regurgitation, diarrhea.\n* Symptoms suggestive of a possible gastric motility disorder during the 60 days prior to screening including: nausea, vomiting, early satiety, post-prandial feeling of fullness or bloating.\n* Tolerance and willingness to consume the oatmeal meal in this study.\n\nExclusion Criteria:\n\n* Diagnosis of eosinophilic enteritis.\n* Inflammatory bowel disease (e.g., Crohn's disease or ulcerative colitis).\n* Known disorders associated with eosinophilic gastrointestinal (GI) diseases (e.g., D 816 V Kit+ systemic mastocytosis, Marfan syndrome or Loey's Dietz Syndrome).\n* Known inflammatory or autoimmune disorders associated with gastric dysmotility such as systemic sclerosis, lupus or eosinophilic fasciitis.\n* Uncontrolled diabetes or known diabetic complications of gastroparesis, neuropathy or nephropathy.\n* Taking opioid agents in the 2 weeks prior to screening and throughout the study.\n* History of strictures in the small bowel or stomach (e.g., pyloric stenosis) or gastric surgeries or procedures such as pyloromyotomy, pyloric dilation, pyloric resection, vagotomy, bariatric surgery or post-Nissen fundoplication or antrectomy with Billroth I, Billroth II or Roux-en-Y gastrojejunostomy.\n* Past or current medical problems or findings such as: advanced liver disease (Child's B or C), acute or chronic renal disease (serum creatinine \\> 3 mg\u002FdL), neurologic disease (e.g., dysautonomia), achalasia and adrenal insufficiency.","ALL","18 Years","59 Years",{"count":89,"type":90},30,"ESTIMATED","OBSERVATIONAL","Purpose:\n\nThe study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment.\n\nHypothesis:\n\nGastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the standard meals used in gastric emptying studies.",[94,95,96],"Eosinophilic Gastritis","Gastroparesis","Gastric Motility Disorder",[98,99,100,101,102,103,104,105,106,107,108,109],"Gastritis","Eosinophilic Gastrointestinal Disorders","Gastric Dysfunction","Gastric Dysmotility","Eosinophils","Eosinophilia","Eosinophilic Disorders","Digestive System Diseases","Immune System Diseases","Stomach Diseases","Gastric Emptying Scintigraphy","Endoscopy","2026-03-26",{"date":112,"type":113},"2026-03-31","ACTUAL",{"date":115,"type":113},"2023-01-25",{"date":117,"type":90},"2026-12-01",{"name":5,"class":6},3]